Journal profile · GASTROENTEROLOGY & HEPATOLOGY
Clinical and Experimental Gastroenterology
ISSN 1178-7023 · Dove Medical Press · United Kingdom
Clinical and Experimental Gastroenterology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.9 (journal website); fully open access; APC about USD 3,940; median 126 days to acceptance (54 articles, last 24 months); acceptance rate 14% (journal website); 25 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Clinical and Experimental Gastroenterology is published by Dove Medical Press and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Inflammatory Bowel Disease, Gastrointestinal motility and disorders and Microscopic Colitis, together about 32.1% of its articles. Its main subfields are Gastroenterology. (generated from OpenAlex topic counts and CAS ranking data)
Editor-in-Chief: Professor Andreas M Kaiser Clinical and Experimental Gastroenterology is an international, peer reviewed, open access journal focusing on all aspects of gastroenterology research, as well as clinical results in human, animal and in vitro studies that shed light on disease processes and potential new therapies. Clinical and Experimental Gastroenterology will no longer consider meta-analyses for publication. Specific topics covered by the journal include: Pathology and pathophysiology of gastrointestinal diseases (including in the liver, gall bladder and pancreas) Investigation and treatment of gastrointestinal diseases Pharmacology of drugs in the alimentary tract Immunology, genetics and genomics related to gastrointestinal diseases Patient safety and quality of care for gastrointestinal diseases The journal accepts papers in the form of original research, short reports, editorials, reviews, and commentaries. Updated 16 July 2025
From the journal's Aims & Scope
Research area (LetPub): GASTROENTEROLOGY & HEPATOLOGY
Editor-in-chief Kaiser DivisionPublisher website
Editorial board by country: 4 in mainland China (about 8%); most named United States 20, Japan 6, India 6, Italy 6, Mainland China 4 (51 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Inflammatory Bowel DiseaseBiochemistry, Genetics and Molecular Biology13.3%
- Gastrointestinal motility and disordersMedicine10%
- Microscopic ColitisMedicine8.7%
- Helicobacter pylori-related gastroenterology studiesMedicine6.2%
- Gastroesophageal reflux and treatmentsMedicine6.2%
- Liver Disease Diagnosis and TreatmentMedicine4.1%
- Gastric Cancer Management and OutcomesMedicine3.9%
- Colorectal Cancer Screening and DetectionMedicine3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Gastroenterology & Hepatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
SJR, OA, CiteScore, Impact FactorPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 2.9Publisher website ·
- 5-year impact factor (publisher)
- 4Publisher website ·
- CiteScore 2026-06
- 4LetPub ·
- CiteScore (publisher) 2025
- 1.07Publisher website ·
- SJR 2026-06
- 0.83LetPub ·
- SNIP 2026-06
- 1.07LetPub ·
- h-index
- 60OpenAlex ·
- i10-index
- 370OpenAlex ·
- 2-year mean citedness
- 2.9OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 98.77%LetPub ·
Volume
- Articles per year
- 25LetPub ·
- Downloads per year (publisher)
- 125,834Publisher website ·
Articles by year OpenAlex count · 617 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 27 | 27 | 16 |
| 2025 | 25 | 25 | 54 |
| 2024 | 30 | 30 | 168 |
| 2023 | 26 | 26 | 250 |
| 2022 | 20 | 20 | 248 |
| 2021 | 51 | 51 | 840 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
126 daysMedian, submission to acceptance · P25–P75 87 days – 146 days
- Acceptance to online
- median 12 days (54 articles)
- Submission to online
- median 137 days
- Sample
- 54 articles with submission and acceptance dates (59 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 16 weeksLetPub ·
- Acceptance rate (publisher)
- 14%Publisher website ·
- Desk decision
- 53 daysPublisher website ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,940 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,320 | — | — | |
| LetPub | USD 2,990 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- case reportAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
- reviewAuthors may use these detailed descriptions of different paper types accepted by Dove Medical Press (case reports, reviews, etc) to decide how to label their pa…Length not stated
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Dove Medical Press
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 1178-7023
- Society / sponsor
- American Society of Colon and Rectal Surgeons
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Clinical and Experimental Gastroenterology
What CAS zone is Clinical and Experimental Gastroenterology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical and Experimental Gastroenterology is in Zone 4 of Medicine, and in Zone 4 of the minor category Gastroenterology & Hepatology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical and Experimental Gastroenterology?
The journal's website gives an impact factor of 2.9 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 4, h-index 60.
How long does peer review take at Clinical and Experimental Gastroenterology?
Based on the dates recorded on 54 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 126 days (interquartile range 87–146 days); authors report an average review time of about 16 weeks; the journal's website gives an acceptance rate of 14%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Clinical and Experimental Gastroenterology based?
Of the 51 board members whose country the journal's board page names, 4 (about 8%) are in mainland China; the countries named most often are United States (20), Japan (6) and India (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinical and Experimental Gastroenterology?
According to LetPub and DOAJ records, Clinical and Experimental Gastroenterology is indexed in ESCI, Scopus and DOAJ.
Is Clinical and Experimental Gastroenterology open access, and what is the APC?
Clinical and Experimental Gastroenterology is a fully open-access journal. APC about USD 3,940.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .